계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
CellSeed
company
About
CellSeed develops regenerative medicine products primarily in Japan and Europe.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- ¥818M
- Industries
- Alternative Medicine,Health Care,Market Research
- Founded date
- May 1, 2001
- Number Of Employee
- 11 - 50
- Operating Status
- Active
CellSeed develops regenerative medicine products primarily in Japan and Europe. The company offers regenerative medicines such as epithelial cell sheet for corneal and esophageal regeneration, regenerated cardiac patch to treat heart diseases, cell sheet for periodontal tissue regeneration, and regenerated cartilage sheet for the treatment of osteoarthritisThe company was founded in 2001 and is headquartered in Tokyo, Japan.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥818M
CellSeed has raised a total of
¥818M
in funding over 2 rounds. Their latest funding was raised on
Nov 2, 2005 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 2, 2005 | Series Unknown | ¥818M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
CellSeed is funded by 1 investors.
Nissei Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Nissei Capital
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
